Microbiota and Neurological Disorders: A Gut Feeling

Area of Science:

• Microbiome research
• Gut microbiota
• Host-microbiome interactions

Background:

• Noncommunicable diseases are now the leading cause of death globally.
• The human microbiome, comprising trillions of commensal microbes, is vital for digestion, drug metabolism, immune function, and protection against environmental exposures.
• Recent focus is on host-microbiome metabolic crosstalk for therapeutic design.

Purpose of the Study:

• To review the potential of synthetic biology and small molecule drugs in modulating the microbiome for therapeutic benefit.
• To highlight the role of epigenetic modifications and histone deacetylase inhibitors in disease treatment.
• To emphasize the diagnostic potential of oral microbiome analysis for gut health.

Main Methods:

• Review of current literature on microbiome research, synthetic biology applications, and small molecule therapeutics.
• Analysis of host-microbiome intermetabolic and crosstalk pathways.
• Exploration of epigenetic mechanisms and their therapeutic implications.

Main Results:

• Synthetic biology offers potential for correcting gut dysbiosis, though clinical proof is pending.
• Small molecule drugs, including approved histone deacetylase inhibitors, have a proven clinical history.
• Preclinical studies indicate promise for epigenetic treatments in neurological disorders.
• The oral cavity serves as an accessible site for early detection of gut pathogens.

Conclusions:

• The human microbiome is integral to health, influencing metabolism, immunity, and environmental interactions.
• Emerging strategies involve synthetic biology and small molecule epigenetic modulators for therapeutic interventions.
• The mouth offers a promising avenue for early diagnostics of gut-related conditions.
• Integrated approaches combining microbiome modulation and diagnostics present a roadmap for novel medicines.